The North American cardiac biomarker market is estimated to grow significantly at a CAGR of around 7.1% during the forecast period. Increasing prevalence of CVDs in The US and Canada, Technological advancement in the cardiac biomarker, and robust healthcare expenditure and R&D in the region is the major fators that contribute to the market growth. According to the American Heart Association (AHA) in 2017, CVD accounts for approximately 800,000 mortalities in the US that is one out of three mortalities. Among every American, an average of one person dies from CVD every 40 seconds. Coronary heart disease (CHD) accounts for most of the CVD Mortalities, followed by stroke and heart failure. In the US per capita, healthcare expenditure is around $10,348 per person, in 2016.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/north-american-cardiac-biomarker-market
The market is segmented on the basis of type, application, and location of testing. Based on type, the market is segregated into Creatine kinase (CK-MB), Troponins (T, I), Myoglobin, Natriuretic peptides (BNP & NT-PROBNP), Ischemia modified albumin and Others. The troponin is anticipated to be the fastest growing and has a considerable market share in the North American cardiac biomarker market due to easy and high sensitivity that results in the high adoption of the test. Based on Application, the market is segmented into myocardial infraction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. On the basis of the location of testing, the market is classified into laboratory testing and point of care testing.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/north-american-cardiac-biomarker-market
The companies which are contributing to the growth of the North American cardiac biomarker market include Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories, Inc., Creative Diagnosis, Critical Diagnostics, Danaher Corp., LifeSign LLC, Meso Scale Diagnostics LLC and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.
Market Segmentation
North American Cardiac Biomarker Market by Type
- Creatine kinase (CK-MB)
- Troponins(T,I)
- Myoglobin
- Natriuretic peptides (BNP & NT-PROBNP)
- Ischemia modified albumin
- Others
North American Cardiac Biomarker Market by Application
- Myocardial infraction
- Congestive heart failure
- Acute coronary syndrome
- Atherosclerosis
- Others
North American Cardiac Biomarker Market by Location of Testing
- Laboratory testing
- Point of care testing
Regional Analysis
- United States
- Canada
Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Co.
- Bio-Rad Laboratories, Inc.
- Creative Diagnosis
- Critical Diagnostics
- Danaher Corp.
- LifeSign LLC
- Meso Scale Diagnostics LLC
- Myriad RBM
- Thermo Fisher Scientific Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
